FutureWise Market Research

FutureWise Market Research We specialise in high-growth niche markets, assuring flexibility, agility and customized solutions for our clients.

22/02/2025

Stem Cell Market Size, Analysis, Trends and Forecast. Get Stem Cell Market Research, Industry Overview and Market Share Reports. FutureWise Market Research - UK and US

22/02/2025

Sleep Apnea Diagnostic Devices Market Analysis, Trends and Forecast. Sleep Apnea Diagnostic Devices Market Industry Overview, Market Growth, Syndicate Report and Business Research Reports – UK and US

Latest FDA approvals have been prompting the growth of the atpic dermatitis treatment market. Pfizer have recieved FDA a...
21/08/2023

Latest FDA approvals have been prompting the growth of the atpic dermatitis treatment market. Pfizer have recieved FDA approval for it's atopic dermatitis. Cibinqo's label expansion was supported from the phase III Jade Teen clinical trial. It includes adolescent aged between 12 - 18 years. Learn more;

Atopic Dermatitis Treatment Market is poised to value over USD 5.5 billion by 2028 at a CAGR of over 8.5% during the forecast period 2022 to 2028.In atopic d...

TheraVet has announced an exclusive distribution agreement for BIOCERA-VET®the products in US. The exclusive partnership...
01/02/2023

TheraVet has announced an exclusive distribution agreement for BIOCERA-VET®the products in US. The exclusive partnership with Invictos Orthopedics will result in an expansion of its orthopedic portfolio, thereby prompting the growth of the veterinary orthopedic implants market. To learn more about the impact of this in the US, visit;

Veterinary Orthopedic Implants Market is poised to register a CAGR of 9% during the forecast period 2022 to 2028.A bone structure that has been injured can b...

Tiba Biotech has signed a deal with the Australian government to develop mRNA vaccines for lumpy skin disease and foot a...
24/11/2022

Tiba Biotech has signed a deal with the Australian government to develop mRNA vaccines for lumpy skin disease and foot and mouth disease. The vaccine would protect the livestock industry and will be ready to use by 2023. mRNA vaccine for foot & mouth disease will be quicker to produce thereby accelerating the growth of the foot and mouth disease market. Get more insights;

Foot and Mouth Disease Vaccines Market is estimated to register a CAGR of over 6.7% during the forecast period 2022 to 2028.Foot and mouth disease (FMD) is a...

The latest FDA clearances are boosting the infusion pump market. FDA has cleared Baxter's Novum infusion pump with Dose ...
12/10/2022

The latest FDA clearances are boosting the infusion pump market. FDA has cleared Baxter's Novum infusion pump with Dose IQ software. The infusion pump offers advanced connectivity and a set portfolio for optimum accuracy alongside configurable anesthesia care settings. Learn more about the market; https://buff.ly/3SLgsTY

Infusion Pumps Market is poised to register a CAGR of 7.3% during the forecast period 2022 to 2028.An infusion pump is a medical device that delivers regulat...

Latest investments are fueling the market growth of the healthcare chatbots market. Mental health chatbot Wysa has score...
11/10/2022

Latest investments are fueling the market growth of the healthcare chatbots market. Mental health chatbot Wysa has scored $20 million in Series B financing led by HealthQuad. The investment will be utilized to expand in lucrative regions like the UK, India, and the US. In addition, the Google Assistant-backed startup that received FDA breakthrough device designation to use chatbots for those who have musculoskeletal will also use the funding to support more languages and include Whatsapp message service. Contact our experts to get a complete overview of the market; https://buff.ly/3eq2p7j

Healthcare Chatbots Market is poised to value USD 1375 million by 2028 end and register a CAGR of 25.1% during the forecast period 2022-2028.The software kno...

Based on recent developments, the  US seems to be the lucrative region for the generic injectables market. Zydus Lifesci...
10/10/2022

Based on recent developments, the US seems to be the lucrative region for the generic injectables market. Zydus Lifesciences has received tentative FDA approval for its generic version of Sugammadex injection. The injection will be available in 2mL and 5mL and will aim to make muscle relax thereby accelerating the growth of the generic injectables market. Contact our experts to understand which region will be lucrative for the production of generic injectables;

Generic Injectables Market is poised to register a CAGR of 12.3% during the forecast period 2022 to 2028.The rising frequency of chronic illnesses has result...

Axsome Therapeutics, Inc. has received FDA approval for its breakthrough rapid-acting treatment of major depressive diso...
21/09/2022

Axsome Therapeutics, Inc. has received FDA approval for its breakthrough rapid-acting treatment of major depressive disorder in adults, Auvelity. It is the first orally administered product with a novel mechanism of action to enter the MDD market in more than 60 years. The dextromethorphan component targets the N-methyl D-aspartate (NMDA) receptor and the sigma-1 receptor in the brain, while the bupropion component acts to increase levels of dextromethorphan in the blood. Click on the link to learn more about how the approval will bolster the antidepressant drugs market;

Antidepressant Drugs Market is poised to register CAGR of 3% during the forecast period 2022 to 2028. Antidepressant Drugs Market is anticipated to attain substantial growth.

FDA has permitted marketing for the first in vitro diagnostic test for early detection of amyloid plaques associated wit...
20/09/2022

FDA has permitted marketing for the first in vitro diagnostic test for early detection of amyloid plaques associated with Alzheimer’s disease. The Lumipulse G β-Amyloid Ratio (1-42/1-40) test is intended to be used in adult patients, aged 55 years and older, presenting with cognitive impairment who are being evaluated for Alzheimer’s disease and other causes of cognitive decline. It can potentially eliminate the need for time-consuming expensive PET scans hence fuelling the growth of the alzheimer's disease diagnostic market. Learn more;

Alzheimer’s Disease Diagnostic Market is poised to value at a CAGR of over 6.2% during the forecast period 2022 to 2028.

Ocelot Bio has received FDA Orphan Drug Designation for its lead candidate OCE-205 for the treatment of hepatorenal synd...
19/09/2022

Ocelot Bio has received FDA Orphan Drug Designation for its lead candidate OCE-205 for the treatment of hepatorenal syndrome. The drug is a peptide therapeutic with a differentiated mechanism of action (MOA) designed to selectively target serious hemodynamic complications that are the result of liver fibrosis and portal hypertension in ESLD. To get a complete overview of how the drug will positively influence the acute kidney injury treatment market, click on the link;

Acute kidney injury treatment market is poised to register a CAGR of 8.2% during the forecast period 2022 to 2028. The market is bifurcated on the basis of type, end-user, and region.

Medtronic’s extravascular ICD meets safety, and efficacy endpoints with a defibrillation success rate of 98.7%. in a rec...
16/09/2022

Medtronic’s extravascular ICD meets safety, and efficacy endpoints with a defibrillation success rate of 98.7%. in a recent study. It is designed to treat fast heart rhythms that can lead to sudden cardiac arrest. The lead is placed under the sternum, which Medtronic says helps avoid complications that can come with leads in the heart and the veins, such as infection or vessel occlusion. Click on the link to learn more about how the activity will positively influence the occlusion devices market;

Occlusion Devices Market Analysis, Trends and Forecast. Occlusion Devices Market Industry Overview, Market Growth, Syndicate Report and Business Research Reports – UK and US

Address

Leeds
LS126LN

Alerts

Be the first to know and let us send you an email when FutureWise Market Research posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to FutureWise Market Research:

Share